We report the isolation and characterization of cDNA clones that encode a protein with the same DNA binding specificity as the immunoglobulin heavy chain enhancer binding protein E {ttEBP-E). We call the gene encoding this protein Ig/EBP-I. A fusion protein encoded by the cDNA binds specifically to ttEBP-E-binding sites (E sites) in both the IgH enhancer and the Vnl promoter. Sequence analysis reveals that Ig/EBP-I is a member of the "basic-zipper" family of DNA-binding proteins that are characterized by basic regions and heptad repeats of leucine residues. Among known family members, Ig/EBP-I demonstrates highest homology to C/EBP throughout the DNA-binding domain and leucine repeat region. Ig/EBP-I and C/EBP have highly overlapping binding specificities; both cloned proteins bind to the IgH enhancer and the VH1 promoter E sites, and Ig/EBP-1 binds to previously characterized C/EBP binding sites in the Rous sarcoma virus (RSV) LTR and the murine albumin promoter. Consistent with their homology in the leucine repeat region, Ig/EBP-I and C/EBP form heterodimers; Ig/EBP-I is the first member of this family that has been found to heterodimerize with the wellcharacterized C/EBP. Ig/EBP-I mRNA is present in all tissues and cell lines examined, although its levels vary almost 20-fold from different sources, with highest levels in early B cells. In tissues where Ig/EBP-1 and C/EBP are both present, heterodimers may be functionally important. The presence of Ig/EBP-I in fibroblasts and other tissues where C/EBP is not expressed suggests that Ig/EBP-I may be functionally important for the activity of the RSV enhancer in these cell types. Finally, elevated expression of Ig/EBP-I in early B cells may explain in part the enhancer-independent activity of Vx promoters early in B-cell development.
SCorresponding author. to these elements have been identified and characterized {Ephrussi et al. 19851 Landolfi et al. 19861 Peterson et al. 1986 , 19881 Schlokat et al. 19861 Sen and Baltimore 19861 Staudt et al. 19861 Weinberger et al. 19861 Lenardo et al. 19871 Peterson and Calame 1987 , 1989 and cDNAs encoding two of them, Oct-2 (Clerc et al. 19881 Staudt et al. 1988} and TFE3 {IxEBP-C2){Beckman et al. 19901 C. Roman and K. Calame, in prep.} have been isolated. Here, we report the isolation and characterization of cDNA clones encoding a polypeptide with the same DNA binding properties as a third IgH enhancer binding protein, ~EBP-E {Peterson and Calame 19871 Peterson et al. 1988}. t~EBP-E is one of three known positive activators that bind with high affinity to both the IgH enhancer and VH promoters {Fig. 1i Peterson et al. 1988} . A second lower affinity site for IxEBP-E has also been mapped to one of
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320 550 E uE1 uE5uE2 uE3 uB E' 8 Figure 1 . Schematic representation of positive acting protein binding sites in the murine IgH enhancer and VH1 promoter. Numbering for the VH1 promoter is from Eaton and Calame (1987) and for the enhancer is from Ephrussi et al. (1985) . Solid ovals (labeled Ig/E) represent mapped Ig/EBP-~EBP-E binding sites ; the high affinity enhancer E site is centered on position 330, and the lower affinity site (E')maps to the most 3' SV40 enhancer core homology at position 475. Sites ~E1, ~E2, and ~E3 are protein-binding sites mapped originally in vivo on the IgH enhancer Ephrussi et al. 1985) . Cloned proteins are represented by shaded ovals; other proteins are represented by empty ovals. Known proteins included in the enhancer diagram are ~EBP-B, which binds to the ~E1 site (Peterson and Calame 1987) ; ~E5-binding proteins (E12/E47, Murre et al. 1989a; ITF-1 and ITF-2, Henthom et al. 1990 ); TF-E3 (Beckman et al. 1990 ; C. Roman and K. Calame, in prep.); ~B, a newly discovered B-cell-specific element (Libermann et al. 1990; Nelson et al. 1990 ); and Oct-2, octamer binding protein which binds the octamer site, 8, in the enhancer.
the SV40 enhancer core homologies in the IgH enhancer (site E', Fig. 1 ; Peterson et al. 1988) . A deletion of the high affinity binding site for ~EBP-E in the IgH enhancer, subsequently referred to as the IgH enhancer E site, reduces enhancer activity to 36% of wild-type levels (Tsao et al. 1988) . A mutation in the E site of the VH1 promoter, which ablates ~EBP-E binding, reduces promoter activity ~-35% (C. Roman and K. Calame, unpubl.) . Our goal is to understand how ~EBP-E contributes to the synergistic ability of IgH enhancer and promoter to activate transcription. ~EBP-E was identified originally by in vitro DNA binding assays in which a portion of the IgH enhancer was used as a probe. Subsequently, ~EBP-E was purified to homogeneity and shown to be a heat-stable polypeptide of --45 kD. Purified ~EBP-E also bound with high affinity to two VH promoters, in the immunoglobulin K (IgK) intron enhancer just upstream of KE1 , and in the T-cell receptor 13 enhancer (McDougall et al. 1988) . ~EBP-E binding activity is present in all tissues and cell types examined (Peterson and Calame 1987; Peterson et al. 1988) . The ubiquitous expression of the protein suggests it may play an important role in regulating transcription of genes in addition to IgH and IgK. We wish to identify such genes so that we may begin to assess the general importance of this transcription factor.
Cloned Ig/EBP-1
Here, we report the isolation and characterization of cDNA clones encoding Ig/EBP-1, a polypeptide that displays ~EBP-E binding specificity. Sequence analysis reveals that Ig/EBP-1 is a member of the basic-zipper family of DNA-binding proteins by virtue of the conservation of two motifs: a "basic region" and a "leucine heptad repeat" (Landschulz et al. 1988a) . Mutational analyses of other members of this family have shown these regions to be critical for DNA binding and protein dimerization, respectively (Gentz et al. 1989; Landschulz et al. 1989; Turner et al. 1989) . Ig/EBP-1 contains striking sequence homology to the CCAAT/enhancer binding protein C/EBP in the basic and leucine repeat regions (Johnson et al. 1987; Landschulz et al. 1988b) . Consistent with this homology, we show that both Ig/ EBP-1 and C/EBP fusion proteins bind to the E sites in the IgH enhancer and that Ig/EBP-1 binds to the C/EBP-EFII site in the Rous sarcoma virus (RSV) long terminal repeat (LTR; Scaly and Chalkley 1987; Ryden and Beemon 1989) and the C/EBP-DBP site in the routine albumin promoter (Lichtsteiner et al. 1987) . We also show that Ig/EBP-1 forms heterodimers with C/EBP; it is the first protein known to be capable of doing so. Northern and RNase protection analyses show that, unlike C/EBP, which is expressed in only a few tissues (Birkenmeier et al. 1989) , Ig/EBP-1 mRNA is present in all cell lines and tissues examined. The occurrence of Ig/ EBP-1, but not C/EBP, in fibroblasts and other tissues suggests that Ig/EBP-1 may be an important activator binding to the EFII site in the LTR of Rous sarcoma virus (RSV) and could help explain the activity of RSV in these cell types.
Results
Isolation and sequencing of cDNA clones for Ig/EBP-1 from L-cell and B-cell cDNA libraries
Because native ~EBP-E is present in low abundance and the purified protein has a blocked amino terminus (C. Peterson and M. Bond, unpubl.) , we chose to screen Kgtll cDNA expression libraries with IgH enhancer E site oligonucleotide probes for phage plaques expressing a ~-galactosidase fusion protein with IgH enhancer E site-specific DNA binding activity (Singh et al. 1987; Vinson et al. 1988) . Initially an oligo(dT) and randomprimed eDNA library from the plasmacytoma line P3XAg8.63 was screened; however, only nonspecific DNA-binding clones were obtained. We then screened 1.6 x 106 recombinant phage from an unamplified cDNA library derived from murine L cells and found one clone, LE1, which was positive. Upon plaque purification, LE1 bound specifically to the IgH enhancer E site probe but not to heterologous probes (data not shown).
A map of phage LE1 is shown in Figure 2A . The clone is unusual in that 516 bp of the f~-galactosidase gene has been deleted (ends at Val 834)and the 5' EcoRI restriction site has been lost. The cDNA insert is 780-bp long and contains a 3' poly(A) segment preceded by a canonical polyadenylation signal (AAUAAA) (Proudfoot and (Fig. 2C ). Additional overlapping eDNA clones for Ig/EBP-1 were obtained by screening amplified P3X and ED20 (pre-B-cell) cDNA libraries with a subfragment of LE1. Several overlapping clones were isolated; one from the ED20 library (BE1) contained additional 5' sequence (see Fig. 2B ). We have not yet cloned the 5' end of the mRNA or the translational initiation codons. The two cDNAs are identical within the overlapping sequence. However, they have different 3' ends, apparently generated by differential polyadenylation; clone LE1 has 250 bp of 3'-untranslated sequence followed by a poly(A) tail, whereas clone BE1 has 480 bp of 3'-untranslated sequence and is not polyadenylated.
Recombinant Ig/EBP-l-fl-galactosidase fusion protein binds specifically to E sites within the IgH enhancer and Vn promoter
It was important to determine whether the protein encoded by our cDNAs had the same DNA binding properties as purified ~EBP-E. Therefore, we tested the ability of the LE1 fusion protein to bind to the IgH enhancer. Figure 3A shows the results of an electrophoretic mobility shift assay (EMSA) in which LE1 fusion protein was used with an IgH enhancer probe. DNA binding activity is present only in IPTG-induced lysogen extracts and can be specifically decreased by competition with excess nortradiolabeled IgH enhancer E site oligonucleotide (E, Fig. 3A ) but not heterologous oligonucleotides ~E1 and ~E3. We believe the high mobility bands from the fusion protein extract represent proteolytic fragments of the fusion protein that retain DNA binding activity because all the complexes are specifically decreased by competition and give the same footprint ( Fig.  3B and data not shown). The LE1 fusion protein also binds specifically to a VH1 promoter probe that contains the E site (second frame; the VH1 probe had lower specific activity than enhancer probe causing the shifted complex to appear fainter).
A more detailed analysis of the DNA-protein interactions was achieved with orthophenanthroline/copper (OP/Cu) chemical nuclease footprint analysis (Fig. 3B) . The LE1 fusion protein protects the same site in the enhancer (lanes 2 and 5) as purified ~EBP-E (Peterson and Calame 1987} . The LE1 fusion protein also footprints the E site in the VH1 promoter {data not shown}. Although the LE1 fusion protein binds specifically to E binding sites, until we have the protein sequence of ~EBP-E we cannot formally conclude that ~EBP-E and the protein produced by the gene we have cloned are the same; therefore we refer to the gene we have cloned and the protein it encodes as "Ig/EBP-I" (Ig/enhancer binding protein-i).
Ig/EBP-1 is a unique single copy gene
The copy number of Ig/EBP-1 was examined by Southern analysis using the LE1 cDNA insert as a probe; a single fragment hybridized to the probe in three different restriction digests (data not shown). We estimate that the limit of homology detected under our conditions is 80% and conclude that there are no other genes closely related to Ig/EBP-1 on the nucleotide level.
The sequence of Ig/EBP-1 predicts a polypeptide which is a member of the "'basic-zipper" family of DNAbinding proteins with particularly high homology to C/EBP The predicted amino acid sequence of cloned Ig/EBP-1 is shown in Figure 4A . It is a member of the family of DNA-binding proteins characterized by a basic region and a heptad repeat of leucine residues, which includes Fos, Jun, C/EBP, ATF 1-8, CREB, GCN4, and many Cloned Ig/EBP-1 others (for review, see Landschulz et al. 1988a; Ziff 1990; Busch and Sassone-Corsi 1990 and references therein). Outside of these conserved domains, Ig/EBP-1 has no recognizable homology to any known member of this family. Mutagenesis of several members of this family has shown that the basic region is necessary for mediating DNA binding, and the leucine zipper is necessary for dimerization (Gentz et al. 1989; Turner et al. 1989) ; by analogy, we expect that this will also be true for Ig/EBP-1. Cloned Ig/EBP-1 shares the highest amino acid sequence homology with C/EBP throughout the basic and zipper regions (Fig. 4B, C) . The leucine zipper regions of Ig/EBP-1 and C/EBP bear striking sequence homology outside of the conserved leucine residues, particularly at the fourth and fifth amino acid residues. In an s-helical structure, these residues would flank the conserved leucine residues on one face of the s-helix; this surface has been proposed to form a hydrophobic dimerization interface between parallel helices (Landschulz et al. 1988a; O'Shea et al. 1989) . There is also striking homology between Ig/EBP-1 and C/EBP in the basic region, where we note 20 of 26 amino acid identity and 22 of 26 identity, allowing for conservative changes (Fig. 4B ). We also note that the consensus binding sequence for purified ~EBP-E (TTNNGCAAT; Peterson et al. 1988 ) is similar to the consensus binding site of C/EBP (see Fig. 5A ; Ryden and Beemon 1989) . We wished to explore this similarity between C/EBP and Ig/EBP-1 further by testing the ability of Ig/EBP-1 to bind to sites originally identified as C/EBP sites and vice versa.
Ig/EBP-1 and C/EBP bind to the same regulatory sites
We tested the ability of Ig/EBP-1 to bind to the wellcharacterized DBP site { -8 3 / -1 1 7 ) i n the murine albumin promoter (Maire et al. 1989} by competition in an EMSA with an IgH E site probe {Fig. 5B). The Ig/EBP-1 fusion protein binding to the IgH enhancer site is decreased by competition with an oligonucleotide containing the C/EBP-DBP site, although ~-10-fold less efficiently than by an IgH enhancer E site competitor. We conclude that Ig/EBP-1 binds to the C/EBP-DBP site in the albumin promoter but with lower affinity than when it binds to the IgH enhancer E site.
We also wished to test the ability of cloned Ig/EBP-1 to bind to the enhancer factor II (EFII) site in the RSV LTR (Sealey and Chalkley 1987; Ryden and Beemon 1989) . EFII was identified originally as a protein from quail fibroblasts (Sealey and Chalkley 1987} that interacts with sequences between -1 9 3 and -231 in the RSV LTR that are critical for wild-type LTR function (Laimins et al. 1984; Cullen et al. 1985a, b; Norton and Coffin 1987;  T. Ryden and K. Beemon, in prep.}. It was demonstrated subsequently that C/EBP binds to the EFII site (Ryden and Beemon 1989) . Figure 5C shows the results of an EMSA in which the probe was a fragment containing the RSV EFII site. These results demonstrate that the Ig/ EBP-1 fusion protein binds specifically to the RSV LTR.
Ig/EBP-1 fusion protein binding to the IgH enhancer is
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,AT AGT (;AC (;AA TAC C(;C G CGC AGA GAG C(;G 2~J~C ~T ATG (;CG GTG 432 decreased efficiently by competition with both E site and EFII site competitors (Fig. 5D ). In addition, Ig/EBP-1 and C/EBP fusion proteins give indistinguishable footprints on the EFII site of the LTR (data not shown). Thus we conclude that cloned Ig/EBP-1 binds with similar affinity to the IgH enhancer E site and the RSV LTR EFII site. Finally, we tested the ability of a C/EBP fusion protein (from a lysogen of phage L20, Landschulz et al. 1988b ) to bind to the E site in the IgH enhancer. Cloned C/EBP gives an OP/Cu endonuclease protection pattern nearly identical to that of Ig/EBP-1 fusion protein (Fig. 3B, lanes  3 and 6) , although the C/EBP fusion protein does not protect the top strand of the enhancer probe as well as does Ig/EBP-1 (cf. lanes 5 and 6). The C/EBP fusion protein also footprints the E site in the V.I promoter in a manner indistinguishable from that of Ig/EBP-1 (data not shown). We conclude that C/EBP binds specifically to IgH E sites, although these data do not allow us to compare the affinity of the two proteins for these sites.
IgEBP and C/EBP from heteromuhimeric complexes
When aligned in an ~ helical wheel representation, the putative dimerization interfaces (formed by amino acids at positions 1 and 5)for Ig/EBP-1 and C/EBP are nearly identical and the chemical nature of some of the flanking amino acid residues is also conserved (Fig. 6C) . This observation and the fact that C/EBP forms homodimers prompted us to determine whether these two proteins were capable of forming heterodimers in vitro. Figure 6A shows that when a truncated C/EBP polypeptide was used in an EMSA with a probe containing a single IgH enhancer E site, a high-mobility complex was observed ( " -I P T G " lanes); two slower mobility complexes were obtained when the same probe was bound by Ig/EBP-1 fusion protein expressed by a LE1 lysogen (LE1 4 ~g, 0 C/EBP, lane 0). When the truncated C/EBP peptide was mixed with the Ig/EBP-1 fusion protein, a new gel mobility-shift complex (marked by an arrowhead) of intermediate mobility was observed in addition to the complexes for C/EBP and Ig/EBP-1 alone. Because intermediate complex formation is dependent on the presence of both C/EBP and Ig/EBP-1, it appears to represent a gel mobility-shift complex formed by a heteromultimer of the two proteins. Figure 6B shows that similar results were obtained using crude nuclear extracts from plasmacytoma P3X as a source of endogenous ~EBP-E. Again, an intermediate gel mobility-shift complex is formed only when both proteins are present. Similar results were obtained using L-cell crude nuclear extracts as a source of endogenous ~EBP-E (data not shown). These results demonstrate that both cloned Ig/ EBP-1 and endogenous ~EBP-E are able to form heteromultimers with C/EBP and that these heteromuhimers bind to the IgH enhancer E site. Because C/EBP (Landschuh et al. 1989 ) and other members of this family (Hope and Struhl 1985; Gentz et al. 1989; Turner and Tjian 1989) have been shown to form dimers and because the mobility of the ~EBP-E, Ig/EBP-1, and heteromuhimeric complexes relative to the C/EBP complex is consistent with their being dimers, we assume that these heteromeric complexes are heterodimers. The demonstration that endogenous ~EBP-E as well as cloned Ig/EBP-1 is capable of complexing with C/EBP
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Ig/EBP-1 is expressed ubiquitously
The similarity in binding specificity of Ig/EBP-1 and C/EBP and their ability to form heterodimers emphasizes the importance of determining the expression pattern of Ig/EBP-1 and comparing it with that of C/EBP. C/EBP mRNA is known to be present in a limited number of nonproliferating tissues (liver, adipose, small intestine, placenta, and lung); its levels are low or absent in dividing cells (Birkenmeier et al. 1989; Xanthopoulos et al. 1989 ; S.L. McKnight, pers. comm.). To determine steady-state levels of Ig/EBP-1 mRNA, the cDNA insert from LE1 was used as a probe in a Northern analysis (Fig.  7A ). The probe hybridized to an mRNA species ~-4.75 kb in length, which is present in adult murine liver, L cells, and the plasmacytoma line P3X. Subsequently, we used an RNase protection assay to better quantify the relative steady-state levels of Ig/EBP-1 mRNA from various sources. The design of the probe allowed 3' ends corresponding to both cDNAs to be individually quantitated (Fig. 7B) . Two protected fragments were anticipated--one of 480 bp, representing the longer 3'-untranslated form and one of 250 bp, representing the shorter 3'-untranslated form (Fig. 7C) . The results from a typical experiment showing the 480-bp fragment and control GAPDH are shown in Figure 7D . A summary of the levels of Ig/EBP mRNA is shown in Figure 7E .
The data confirm that Ig/EBP-1 RNA is present in all tissue types and cell lines examined; the levels vary almost 20-fold between the lowest (muscle) and the highest (pre-B line 22D6). There was, on average, a 4-to 5-fold higher level of Ig/EBP-1 mRNA in pre-B cells than in plasmacytomas. The protected fragment in WEHI 279 is slightly smaller than that seen from other tissues; we believe this is likely to be the result of a polymorphism in the Ig/EBP-1 gene in this cell line. The amount of the 250-bp fragment (shorter 3'-untranslated form) in different tissues varies, from nearly undetectable levels in some early B-cell lines to as much as 40% of the 480-bp Ig/EBP-1 fragment in HPC M2 plasmacytoma. It is not known if different 3'-untranslated ends for Ig/EBP-1 mRNA are functionally important although it is possible that they confer differential stability to the mRNAs. Our data make it clear that Ig/EBP-1 is expressed very differently from C/EBP. Ig/EBP-1 mRNA is present ubiquitously, both in dividing ceils and proliferating tissues as well as other tissues. These data are consistent with earlier EMSAs showing that ~EBP-E binding activity was ubiquitous (Peterson and Calame 1987) .
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Discussion
We report the isolation and characterization of cDNA clones encoding a protein whose DNA binding characteristics and expression pattern correspond to that of a previously described transcription factor, ~EBP-E. The gene encoding this protein, which we call Ig/EBP-1, appears to be a single-copy gene that encodes a member of the basic-zipper family of DNA-binding proteins. Ig/ EBP-1 has high homology to C/EBP in the basic region, which contacts DNA, and the leucine zipper region, which is a dimerization domain. Consistent with the amino acid sequence conservation in the basic region, both Ig/EBP-1 and C/EBP bind to the IgH enhancer and VH1 promoter E sites, the C/EBP-DBP site in the albumin promoter, and the EFII site in the RSV LTR. Consistent with the sequence similarities in the leucine zipper, Ig/EBP-1 and C/EBP form heterodimers in vitro.
In contrast to C/EBP, Ig/EBP-1 mRNA is present in all ceils tested, although relative levels vary by about 20-fold; highest levels are found in early B cells.
Ig/EBP-1 levels in B cells and the possible role of Ig/ EBP-1 m enhancer-independent transcription from Vn promoters
In early B cells, low-level transcription occurs from unrearranged germ line VH genes (Yancopoulos and Alt 1985) ; this transcription is believed to be important for targeting the locus for DNA rearrangement by making the VH gene segments accessible to the VDJ recombinase machinery. Upon rearrangement, transcription from the rearranged VH gene is activated by the IgH enhancer, and in later B cells there is no evidence of enhancer-independent germ line VH transcription. Three factors, ~EBP-E, ~EBP-C2, and Oct-2, bind in both the IgH enhancer and VH1 promoter. We speculated previously ) that elevated levels of one, or a combination, of these three factors in early B cells may allow enhancerindependent activity of VH promoters, whereas limiting factor levels in later B cells would make VH promoters enhancer dependent. This model assumes that enhancers function to concentrate required transcription proteins near the transcription initiation site, although it makes no predictions as to how this is achieved or how the proteins subsequently activate transcription. By use of sensitive RNase protection studies, we now show that levels of Ig/EBP-1 mRNA are on averge four to five times higher in early B cells than in plasmacytomas. Although we do not yet know the relative levels of Ig/ EBP-1 protein or required threshold levels of the protein for IgH gene transcription, the elevated mRNA levels in early B cells are consistent with the possibility that increased levels of Ig/EBP-1 could be important for the enhancer-independent activity of VH promoters in early B cells. Because Ig/EBP-1 mRNA levels are similar in pre-B-cell lines which do {40E3, 22D6, 38B9} and do not (300-10, 300-18} express germ line transcripts (Ramakrishnan and Rosenberg 1988}, additional factors must also affect enhancer-independent transcription.
Cold 
The possible role of Ig/EBP-1 in retroviral enhancer activity
Our data show that Ig/EBP-1 binds to the EFII site in the LTR of RSV, a positive regulatory site that is essential for LTR enhancer activity (Laimins et al. 1984; Cullen et al. 1985a, b; Norton and Coffin 1987; T. Ryden and K. Beemon, in prep.) . Although RSV is an avian retrovirus, the activity of the viral LTR in murine tissues is well documented (Luciw et al. 1983; Overbeek et al. 1986 ). EFII-like sites occur in a number of other avian retroviral LTRs including ALV and in an internal RSV enhancer (gag) (Carlberg et al. 1988) , and proteins have been reported that interact with these elements (Karnitz et al. 1987 (Karnitz et al. , 1989 Ruddel et al. 1988 Ruddel et al. , 1989 . C/EBP has been shown to bind to the EFII site in the RSV LTR, to related sites in several other retroviral LTRs (Johnson et al. 1987; Ryden and Beemon 1989) , and to the RSV internal (gag) enhancer (Carlberg et al. 1988) . However, the limited pattern of C/EBP mRNA expression is inconsistent with the possibility that it mediates the enhancer activity of the RSV LTR or gag enhancers in all the murine tissues and cell types where these enhancers are known to be active (Overbeek et al. 1986; T. Ryden and K. Beemon, in prep.) . Given the ability of Ig/EBP-1 to bind the EFII site and the fact that Ig/EBP-1 mRNA is expressed in cell types where the RSV LTR is active (Luciw et al. 1983) , we postulate that Ig/EBP-1 may be important for the enhancer activity of RSV and murine retroviral LTRs (Johnson et al. 1987) .
The relationship between Ig/EBP-1, C/EBP, and other family members
The overlapping DNA binding specificities of Ig/EBP-1 and C/EBP are striking and raise the problem of assessing which protein or proteins are functionally important in the regulation of genes where two or more proteins bind to one important regulatory site. Similar questions are posed by the growing number of proteins that bind to ATF sites (Hai et al. 1989) , homeotic protein-binding sites (Han et al. 1989) , and octamer sites (Scholer et al. 1989) . We have shown that Ig/EBP-1 is expressed in liver and
Cold Spring Harbor Laboratory Press on December 22, 2017 -Published by genesdev.cshlp.org Downloaded from that it binds to the DBP site of the albumin promoter in vitro; however, we do not know if Ig/EBP-1 can activate albumin gene transcription in vivo. At least two other proteins, C/EBP and DBP (Mueller et al. 1990} , are also known to bind to and activate the albumin promoter at this site; their expression is partially restricted to liver. Albumin promoter activity in vivo and occupation of the DBP site in vitro is liver specific and correlates with C/EBP mRNA expression {Lichtsteiner et al. Friedman et al. 19891 ; this indirectly suggests that Ig/EBP-1 by itself may not form a stable interaction at the albumin promoter in vivo. However, all the data are consistent with the possibility that Ig/EBP-C/EBP heterodimers bind at the DBP site to activate the albumin promoter. We have demonstrated the ability of Ig/EBP-1 and C/EBP to form heterodimers in vitro; Ig/EBP-1 is the only protein known to interact with C/EBP. Ig/EBP-1-C/EBP heterodimers may be functionally important in the context of the albumin promoter and other genes that appear to depend on C/EBP {for review, see Costa et al., 1988; Christy et al. 1989 ; Kaestner et al. 1989; McKnight et al. 1989 ) because we have found that heterodimers have a higher affinity for the albumin promoter DBP site than C/EBP homodimers (C. Roman and K. Calame, unpubl.) . This may be similar to the situation reported recently for MyoD1, a tissue-specific master regulator of myogenesis (Weintraub et al. 1989} , which forms heterodimers with ubiquitously expressed E47 {Murre et al. 1989b} . Further exploration of the role of Ig/EBP-1 in the function of the albumin promoter may reveal important aspects of how transcription factors interact with one another to modulate transcription.
1987;
In tissues such as lymphoid tissues where C/EBP is not expressed, Ig/EBP-1-C/EBP heterodimers could not form, and Ig/EBP-1 alone may activate genes dependent on Ig/EBP-1 sites. However, C/EBP is not the only protein that shares considerable homology to Ig/EBP-1. There have been reports of other members of this C/EBP family of DNA-binding proteins {S. Akira et al. 1990; McKnight, pets. comm.; C.J. Chang and S.C. Lee, pets. comm.} that are unrelated to Ig/EBP-1 except in the region of DNA binding and dimerization. This is similar to the ATF and POU/homeo box families of DNAbinding proteins, which are related in amino acid sequence to each other and in the nucleotide sequences to which they bind {Herr Hai et al. 1989) . The existence of these clones suggests that the purified ~EBP-E described previously )could be a mixed population of heterodimers. These data also suggest the potential complexity of how transcriptional regulation may be achieved through Ig/EBP-1 binding sites. It is likely that the members of the C/EBP family are able to bind related sequences with varying affinities; they may form a variety of heterodimers with differential binding affinities, transcriptional regulating activities, and stabilities. Thus it will be necessary ultimately to understand the tissue distribution, the ability to form heterodimers, and the functional activity of heterodimers formed by all the members of this growing family. As more genes are cloned, it will become possible to address these complex issues.
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Methods
Isolation of Ig/EBP-1 recombinant phage
We used the screening strategy of Singh et al. (1988) with modifications introduced by Vinson et al. (1988) to obtain one clone (LE1), which bound specifically to an oligomerized IgH enhancer E site oligonucleotide from a primary screen of 1.6 x 106 unamplified recombinant phage containing oligo(dT) and random-primed L-cell cDNA (Clontech). An overlapping clone (BE1) was obtained by conventional nucleic acid hybridization by use of an EcoRI-SstI 0.6-kb fragment from the LE1 cDNA insert to screen an oligo{dT)-primed lambdaZAP {Strata-gene) cDNA library from the pre-B-cell line ED20, subline of 18-81 (gift of Paul Rothman). This fragment spans the sequences between an SstI site at nucleotide 366 {Fig. 3A) and the EcoRI site 3' of the poly{A) tail. The phage L20 contains the DNA-binding and dimerization domain of C/EBP (Landschulz et al. 1988b ; gift of S.L. McKnight).
Protein preparation
Lysogen extracts for LE1 and L20 were made as described in Landschulz et al. (1988b) .
Southwestern analysis
Proteins in 50 ~g of lysogen extract were separated by SDS/5%-PAGE {Laemmli 1970)and transferred to nitrocellulose in 0.025 M Tris base, 0.192 M glycine. Filters were then processed and incubated with oligomerized E site probe in the same manner as were the plaque lifts for DNA binding activity.
EMSAs and OP/Cu footprinting
Probes for footprinting were end-labeled by T4 polynucleotide kinase and gel-purified as described (Maxam and Gilbert 1977}. 1-3 x 104 and 3 x l0 s cpm of probe {0.3-1.0 ng and 10 ng) were used per analytical and preparative EMSAs, respectively. Analytical gel mobility-shifts were performed by use of 2-4 ~g of lysogen extract, 2 ~g of poly[d{I-C)] (Pharmacia), and 50 ng of sheared salmon sperm DNA in ~EBP-E binding buffer {10 mM Tris, 80 mM NaC1, 8 mM MgC12, and 10% glycerol}. Competitors or water were preincubated for 10 min with protein at room temperature prior to the addition of probe. Binding reactions were incubated at room temperature for 20 min and loaded directly onto a 6% polyacrylamide gel and electrophoresed at 20 mA constant current in 1 x TBE {Peterson et al.
1988}. Preparative gel mobility-shifts for footprinting were performed with 40 ~g of lysogen extract and 40 ~g of poly[d{I-C)] in binding buffer in a total volume of 75 ~1 and incubated at room temperature for 30 min. After electrophoresis, gels were treated in situ with the chemical endonuclease OP/Cu as described {Kuwabara and Sigman 1987). Free and bound complexes were visualized by autoradiography, cut out and eluted from the gel. The DNA was then run out on a 10% sequencing gel with G and G + A ladders (Maxam and Gilbert 1977) and visualized by autoradiography. The IgH enhancer and murine albumin promoter competitors used in this study were all ~-200-bp fragments synthesized by PCR amplification using the M13 universal and pUC reverse primers to amplify multimerized binding site oligonucleotides inserted into the polylinker of a pUC plasmid. The DBP-site competitor (the kind gift of S. Tilghman) contained 3 copies of the murine albumin DBP site{-83/-117); the IgH enhancer E site oligo contained 4 copies of the sequence 324 to 343 of the murine IgH enhancer {Peterson and Calame 1987}, and the IgH enhancer ~E1 and ~E3 competitors contained 4 copies of the murine IgH enhancer sequence 344 to 365 and 390 to 409, reCold Spring Harbor Laboratory Press on December 22, 2017 -Published by genesdev.cshlp.org Downloaded from spectively. The EFII competitor oligo (the kind gift of M.G. Rosenfeld) was a 44-bp double-stranded oligonucleotide spanning sequences -231 to -193 from the RSV-SRD LTR.
Heterodimer formation between native laEBP-E or Ig/EBP-1 fusion protein with the C/EBP BR-A peptide was monitored by the method of Hope and Struhl (1987) . The BR-A peptide spans amino acids Ash281 through Ala358 (Landschulz et al. 1988a) and was overproduced and purified from Escherichia coli (J. Shuman and S.L. McKnight, in prep.). Crude nuclear extract (4 lag) or lysogen extract (2 lag) was incubated in the presence of 0, 1, 5, or 10 ng of the C/EBP peptide BR-A and 1 ~g of acetylated BSA. The BR-A peptide and the indicated protein extracts were incubated in BR-A binding buffer [10 mM HEPES (pH 8.0), 10% glycerol, 5 mM KC1, 0.1 mM EDTA, 0.25 mM DTT, and 2 mM MgCl~) for 5 rain at room temperature prior to the addition of probe. Electrophoresis was performed in a 6% polyacrylamide gel in 0.5 x TBE at 10 V/cm constant voltage. For these experiments, the probe was an end-labeled 104-bp PCR fragment spanning the polylinker of pUC with one IgH enhancer E site oligo inserted into the HincII.
Sequence analysis
Sequencing of M13, pUC (BRL), and pSK-(Stratagene) containing subclones of the eDNA inserts was performed by Ulla Beauchamp in the DNA Sequencing Facility (Columbia University) using the dideoxy chain-termination technique with dyeconjugated primers and an ABI sequenator.
Northern and Southern analysis
Total RNA was isolated from pelleted tissue-culture cells or tissues frozen in liquid N~ by the guanidiniumisothiocyanate method as described (Chirgwin et al. 1979) . Polyadenylated RNA was selected on an oligo(dT)resin (BMB). Formaldehyde gel electrophoresis was performed as described (Maniatis et al. 1982) .
Genomic DNA (15 lag) from 18-81 DNA was digested to completion and run on a 1% agarose gel and blotted according to standard protocols. Northern and Southern blots were probed with the EcoRI-SstI 0.6-kb fragment of Ig/EBP-1 cDNA labeled by random priming (Feinberg et al. 1984) .
RNase protection assays
The clone BE1 was used as a template for T7 polymerase (Stratagene) to generate an antisense riboprobe for Ig/EBP-1 transcripts according to the manufacturer's instructions essentially as described (Eaton and Calame 1987; Melton et al. 1984) . Band intensities of autoradiographs with linear range exposures were quantitated by scanning densitometry with the LKB Ultrascan Densitometer XL. The rat GAPDH 1.2-kb PstI fragment eDNA (Fort et al. 1985) was inserted into pKS-(Stratagene) and also used as a template for T7 polymerase. Hybridization to this GAPDH probe yielded several bands due to cuts at polymorphic sites. The bands were shown to be specific for GAPDH, and band intensity increased linearly with increasing amounts of RNA within the context of the assay. The two major GAPDH bands were quantitated and averaged and did not vary significantly with respect to one another between cell types or experiments. BE1 (50,000 cpm) and GAPDH (5000 cpm)riboprobes were added from a mix of both probes to 50-100 lag of total RNA.
